Compliance Advantage Synchrony Labs emphasizes a stellar compliance record and extensive preclinical experience in safety, toxicology, and efficacy studies, making it a low-risk partner for medical device and biotech companies seeking a reliable path to clinical trials.

Structural Heart With the launch of the William O’Neill Structural Heart Center, the company signals dedicated capabilities for cardiovascular and structural heart device preclinical work, offering specialized services that can de-risk product development for cardiac teams.

Local Ecosystem Located in Durham with origins at Duke Medical Center, Synchrony Labs sits in the North Carolina biotech corridor and can leverage university partnerships and regional CRO networks to accelerate project readiness and sponsor collaborations.

Customer Focus Recent appointment of a Customer Relations Manager demonstrates a commitment to high-touch client services; this can support longer-term programs, cross-selling preclinical services, and stronger retention with clear account management.

Mid-market Advantage As a nimble, mid-sized CRO with a credible track record and ongoing device and pharma partnerships, Synchrony Labs can offer flexible engagement models, rapid start-to-study timelines, and tailored preclinical programs to mid-market biotech and medical device companies seeking cost-effective, scalable support.